Department of Urology, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY.
University Hospitals Cleveland Medical Center, Urology Institute, Cleveland, OH, USA; Department of Urology, Case Western Reserve University School of Medicine, Cleveland, OH.
Urol Oncol. 2021 Jan;39(1):6-12. doi: 10.1016/j.urolonc.2020.08.009. Epub 2020 Oct 27.
Robot-assisted radical cystectomy (RARC) remains one of the most complex urological procedures. Due to regionalization of bladder cancer care, there is likely an imbalance in experience among urologists performing RARC. We sought to describe changes in patient selection, surgical quality surrogates and rates of complications in relation to surgical experience.
We retrospectively reviewed 409 consecutive patients with bladder cancer who underwent RARC between 2006 and 2017 by a single surgeon. The cohort was divided into 4 quartiles (Q1-Q4) according to surgical experience, based on the chronologic order at which RARC was performed. Baseline, perioperative and pathologic characteristics of patients were compared among the 4 groups. 30-day and 90-day complications were assessed using the Clavien-Dindo system. The association between surgical experience (quartile) and complications was assessed using multivariable logistic regression analyses.
Median age (interquartile range [IQR] from 70-73 years), body mass index (IQR from 25 to 27 kg/m) and preoperative glomerular filtration rate (IQR from 59 to 65 ml/min) were similar among all quartiles (all P > 0.05). Patients in Q4 had higher rates of previous abdominopelvic surgery (46.1% vs. 30.4%, P = 0.031) and American Society of Anesthesiologists score of 3 to 4 (72.3% vs. 47.1%, P = 0.003) compared to patients in Q1. Patients who underwent RARC in Q4 compared to Q1, had less estimated blood loss (250 ml vs. 350 ml, P < 0.001), shorter operative time (346 vs. 360 minutes, P < 0.001), and higher lymph node yield (22 vs. 17 nodes, P < 0.001). The 30-day and 90-day complication rates were 53% and 62%, respectively. Thirty-day complication rates were similar among all 4 quartiles (P > 0.05), but higher among patients in Q4 compared to Q1 within 90 days (74% vs. 54%, P = 0.01). On multivariable analysis, patients in Q4 were more likely to experience any 90-day complication (OR 2.03, 95%Cl 1.11-3.70) compared to Q1.
Our results show that with surgical experience, more complex cases can be performed while continuing to improve surgical quality. Nonetheless, there appears to be a trade-off between the increase in complexity of cases performed with experience and accepting higher rates of complications.
机器人辅助根治性膀胱切除术(RARC)仍然是最复杂的泌尿科手术之一。由于膀胱癌治疗的区域化,进行 RARC 的泌尿科医生的经验可能存在不平衡。我们旨在描述与手术经验相关的患者选择、手术质量替代指标和并发症发生率的变化。
我们回顾性分析了 2006 年至 2017 年间由一位外科医生对 409 例膀胱癌患者进行的连续 RARC。根据 RARC 进行的时间顺序,根据手术经验将队列分为 4 个四分位数(Q1-Q4)。比较 4 组患者的基线、围手术期和病理特征。使用 Clavien-Dindo 系统评估 30 天和 90 天的并发症。使用多变量逻辑回归分析评估手术经验(四分位数)与并发症之间的关联。
中位数年龄(70-73 岁,四分位距 [IQR])、体重指数(25 至 27 kg/m,IQR)和术前肾小球滤过率(59 至 65 ml/min,IQR)在所有四分位数中均相似(均 P > 0.05)。与 Q1 相比,Q4 中的患者既往腹盆部手术(46.1% vs. 30.4%,P=0.031)和美国麻醉师协会评分 3-4(72.3% vs. 47.1%,P=0.003)更高。与 Q1 相比,Q4 中接受 RARC 的患者出血量更少(250 ml 与 350 ml,P<0.001),手术时间更短(346 分钟与 360 分钟,P<0.001),淋巴结检出数更高(22 个与 17 个,P<0.001)。30 天和 90 天的并发症发生率分别为 53%和 62%。4 个四分位数的 30 天并发症发生率相似(P>0.05),但 Q4 患者在 90 天内的并发症发生率高于 Q1(74% vs. 54%,P=0.01)。多变量分析显示,与 Q1 相比,Q4 患者 90 天内发生任何并发症的可能性更高(OR 2.03,95%Cl 1.11-3.70)。
我们的结果表明,随着手术经验的增加,可以进行更复杂的病例,同时继续提高手术质量。尽管如此,在手术经验增加和接受更高并发症发生率之间似乎存在权衡。